2023-10-07 11:00:00

Leaders in Health Care 2022: Dr. Victor Velculescu, Delfi Diagnostics

Logo The Business Journals
The Business Journals

Velculescu has worked in cancer genomics for decades.

AD
AD

Continue read on bizjournals.com

AD
Logo Benzinga
Business / FinanceBy Business Wire2023-09-29 18:20:00
VieCure Inc., a cancer care company with a market-leading artificial intelligence, informatics, and clinical decision support platform, announces further...

Logo PR Newswire
TechnologyPress Release2024-09-27 14:46:00
AURORA, Colo., Sept. 27, 2022 /PRNewswire/ -- Foresight Diagnostics, Inc, a leader in cancer diagnostics and cancer relapse testing, announced today that the...

Logo U.S. News & World Report
PoliticsBy Health Day2023-10-04 10:35:00
By Ernie Mundell HealthDay Reporter Disabled patients face discrimination from doctors. More than three decades after the passage of the Americans with...

Logo EIN Presswire
PoliticsPress Release2023-09-29 10:00:00
Dr. Jessica Nouhavandi of Honeybee Health for TIME 100 Next 2022 In 2020, Nouhavandis mail-order pharmacy, Honeybee Health, became the first in the U.S. to...

Logo InvestorPlace
MarketsBy William White2023-10-05 13:42:39
Source: Dennis Diatel / Shutterstock.com Bionano Genomics (NASDAQ: BNGO ) stock is rising higher on Wednesday following the publication of a study related to...

Logo Benzinga
MarketsBy Adam Eckert2023-10-05 13:33:57
Bionano GenomicsInc BNGO shares continue to tradehigher Wednesday after the company on Tuesday highlighted a study showing thatoptical genome mapping better...

Logo Benzinga
Business / FinanceBy Business Wire2024-09-21 13:20:00
Presentations Demonstrate the P ower of Integrated Analysis to Discover Distinct Characteristics of the Tumor Microenvironment Leading to Positive Clinical...

Logo EIN Presswire
EpiAxis Therapeutics is based in Sydney, Australia. EpiAxis Therapeutics and Canada's University Health Network have entered a collaboration to study a new...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-09-13 08:03:36
Dublin, Sept. 13, 2022 (GLOBE NEWSWIRE) -- The Circulating Tumor Cell Diagnostics Market Forecast to 2028 - COVID-19 Impact and Global Analysis By...

Logo Benzinga
Business / FinanceBy Pr Newswire2024-09-14 13:15:00
Six startups from Indonesia, Ireland, Israel, South Africa, United Kingdom and the United States will receive seed investment and access to technology and...

Logo U.S. News & World Report
PoliticsBy Health Day2024-09-09 11:07:00
By Ernie Mundell HealthDay Reporter Artificial sweeteners may harm the heart. Sugar substitutes are a popular way to try to keep slim, but French research...

Logo Benzinga
Business / FinanceBy Business Wire2024-09-14 15:36:00
Groundbreaking Program Supporting Women in Cancer Treatment Honors Legends, Advocates, Survivors Look Good Feel Better, the global charitable organization...

Logo The Motley Fool
MarketsBy Newsfeedback@Fool Com (The Daily Upside)2023-09-30 01:00:19
For more crisp and insightful business and economic news, subscribe to The Daily Upside newsletter. It's completely free and we guarantee you'll learn...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-09-16 07:48:09
New York, Sept. 16, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report Point-Of-Care Molecular Diagnostics Global Market Report...

Logo U.S. News & World Report
PoliticsBy Health Day2024-09-13 11:06:00
By Ernie Mundell HealthDay Reporter TikTok 'slugging' trend has kids coating their faces with grease. It's touted to help moisturize the skin, but slugging...

Logo Benzinga
Business / FinanceBy Globe Newswire2024-09-15 08:43:32
Dublin, Sept. 15, 2022 (GLOBE NEWSWIRE) -- The Biochips Market, By Product, By Application, By Substrate Materials, By Technology, By End-Use, and By Region...

Logo U.S. News & World Report
PoliticsBy Health Day2024-09-14 10:06:00
By Ernie Mundell HealthDay Reporter Cancers in people under 50 are rising worldwide. While the reasons for the trend aren't clear, it's likely that changes...

Logo EIN Presswire
Discovery of Notch Inhibitors for Cancer Therapy DOVER, DELAWARE, UNITED STATES, September 18, 2024 / EINPresswire.com / -- GLAX Health Announces the...

Logo Benzinga
Business / FinanceBy Business Wire2024-09-09 14:32:00
Tempus, a leader in artificial intelligence and precision medicine, today announced three abstracts were accepted for presentation at the European Society...

Logo Benzinga
Business / FinanceBy Business Wire2024-09-11 06:30:00
Findings from ancillary study of Phase 3 STAMPEDE trial reveal Decipher Prostate test is prognostic for clinical outcomes in men with high-risk...